Cargando…

NIK links inflammation to hepatic steatosis by suppressing PPARα in alcoholic liver disease

Background: Inflammation and steatosis are the main pathological features of alcoholic liver disease (ALD), in which, inflammation is one of the critical drivers for the initiation and development of alcoholic steatosis. NIK, an inflammatory pathway component activated by inflammatory cytokines, was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yaru, Chen, Mingming, Zhou, Yu, Tang, Chuanfeng, Zhang, Wen, Zhong, Ying, Chen, Yadong, Zhou, Hong, Sheng, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069072/ https://www.ncbi.nlm.nih.gov/pubmed/32206109 http://dx.doi.org/10.7150/thno.40149

Ejemplares similares

Depdc5 deficiency exacerbates alcohol-induced hepatic steatosis via suppression of PPARα pathway
por: Xu, Lin, et al.
Publicado: (2021)

Suppression of PPARγ-mediated monoacylglycerol O-acyltransferase 1 expression ameliorates alcoholic hepatic steatosis
por: Yu, Jung Hwan, et al.
Publicado: (2016)

PPARα Is Required for PPARδ Action in Regulation of Body Weight and Hepatic Steatosis in Mice
por: Garbacz, Wojciech G., et al.
Publicado: (2015)

CCN1 promotes hepatic steatosis and inflammation in non-alcoholic steatohepatitis
por: Ju, Linling, et al.
Publicado: (2020)

Novel PPARα agonist MHY553 alleviates hepatic steatosis by increasing fatty acid oxidation and decreasing inflammation during aging
por: Kim, Seong Min, et al.
Publicado: (2017)

Modulation of liver steatosis by miR-21/PPARα
por: Rodrigues, Pedro M., et al.
Publicado: (2018)

Aging‐induced aberrant RAGE/PPARα axis promotes hepatic steatosis via dysfunctional mitochondrial β oxidation
por: Wan, Jian, et al.
Publicado: (2020)

Plug in with Nik software: a photographer's guide to creating dynamic images with Nik software
por: Batdorff, John
Publicado: (2013)

Inhibition of DHCR24 activates LXRα to ameliorate hepatic steatosis and inflammation
por: Zhou, Enchen, et al.
Publicado: (2023)

Rev-erbα exacerbates hepatic steatosis in alcoholic liver diseases through regulating autophagy
por: Liu, Qingxue, et al.
Publicado: (2021)

Expression of Nik-related kinase in smooth muscle cells attenuates vascular inflammation and intimal hyperplasia
por: Lu, Yi-Jhu, et al.
Publicado: (2020)

Disturbances in the murine hepatic circadian clock in alcohol-induced hepatic steatosis
por: Zhou, Peng, et al.
Publicado: (2014)

Study on the Grading Model of Hepatic Steatosis Based on Improved DenseNet
por: Yang, Ruwen, et al.
Publicado: (2022)

Targeting NF-κB-Inducing Kinase (NIK) in Immunity, Inflammation, and Cancer
por: Pflug, Kathryn M., et al.
Publicado: (2020)

Hepatic NF-kB-inducing kinase (NIK) suppresses mouse liver regeneration in acute and chronic liver diseases
por: Xiong, Yi, et al.
Publicado: (2018)

Betaine in ameliorating alcohol-induced hepatic steatosis
por: Rehman, Aisha, et al.
Publicado: (2021)

Alcohol-related changes in the intestinal microbiome influence neutrophil infiltration, inflammation and steatosis in early alcoholic hepatitis in mice
por: Lowe, Patrick P., et al.
Publicado: (2017)

Fat mass and obesity–associated protein promotes liver steatosis by targeting PPARα
por: Wei, Xiaohui, et al.
Publicado: (2022)

Suppression of Th17 cell differentiation by misshapen/NIK-related kinase MINK1
por: Fu, Guotong, et al.
Publicado: (2017)

Islet α-cell Inflammation Induced By NF-κB inducing kinase (NIK) Leads to Hypoglycemia, Pancreatitis, Growth Retardation, and Postnatal Death in Mice
por: Li, Xinzhi, et al.
Publicado: (2018)

PPARδ attenuates hepatic steatosis through autophagy-mediated fatty acid oxidation
por: Tong, Lei, et al.
Publicado: (2019)

SM22α suppresses cytokine-induced inflammation and the transcription of NF-κB inducing kinase (Nik) by modulating SRF transcriptional activity in vascular smooth muscle cells
por: Dai, Xiaohua, et al.
Publicado: (2017)

NIK flips the switch on Arp2/3
por: Leslie, Mitch
Publicado: (2015)

Saving β cell function in the NIK of time
por: Tarbell, Kristin V., et al.
Publicado: (2015)

Catalytic subunits of the phosphatase calcineurin interact with NF-κB-inducing kinase (NIK) and attenuate NIK-dependent gene expression
por: Shinzawa, Miho, et al.
Publicado: (2015)

Correction: Alcohol-related changes in the intestinal microbiome influence neutrophil infiltration, inflammation and steatosis in early alcoholic hepatitis in mice
por: Lowe, Patrick P., et al.
Publicado: (2017)

Berberine Ameliorates Hepatic Steatosis and Suppresses Liver and Adipose Tissue Inflammation in Mice with Diet-induced Obesity
por: Guo, Ting, et al.
Publicado: (2016)

Activation of PPARα Ameliorates Hepatic Insulin Resistance and Steatosis in High Fructose–Fed Mice Despite Increased Endoplasmic Reticulum Stress
por: Chan, Stanley M.H., et al.
Publicado: (2013)

Wedelolactone Regulates Lipid Metabolism and Improves Hepatic Steatosis Partly by AMPK Activation and Up-Regulation of Expression of PPARα/LPL and LDLR
por: Zhao, Yun, et al.
Publicado: (2015)

NF-kappaB inducing kinase (NIK) is a key regulator of inflammation-induced angiogenesis
por: Noort, Ae-Ri, et al.
Publicado: (2012)

mTORC1 activation is not sufficient to suppress hepatic PPARα signaling or ketogenesis
por: Selen, Ebru S., et al.
Publicado: (2021)

Suppression of Hepatic PPARα in Primary Biliary Cholangitis Is Modulated by miR-155
por: Adamowicz, Monika, et al.
Publicado: (2022)

Miltefosine Suppresses Hepatic Steatosis by Activating AMPK Signal Pathway
por: Fang, Ru, et al.
Publicado: (2016)

Antioxidant Stress and Anti-Inflammation of PPARα on Warm Hepatic Ischemia-Reperfusion Injury
por: Gao, Zhixin, et al.
Publicado: (2012)

Palmitoleate attenuates diet induced insulin resistance and hepatic inflammation independently of PPAR-α
por: Souza, Camila O, et al.
Publicado: (2014)

Glucocorticoids increase skeletal muscle NF‐κB inducing kinase (NIK): links to muscle atrophy
por: Fry, Christopher S., et al.
Publicado: (2016)

High-Fat Diet-Induced Adiposity, Adipose Inflammation, Hepatic Steatosis and Hyperinsulinemia in Outbred CD-1 Mice
por: Gao, Mingming, et al.
Publicado: (2015)

The Therapeutic Potential of Targeting NIK in B Cell Malignancies
por: Haselager, Marco V., et al.
Publicado: (2022)

Biliary NIK promotes ductular reaction and liver injury and fibrosis in mice
por: Zhang, Zhiguo, et al.
Publicado: (2022)

NF-κB-inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action
por: Sheng, Liang, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_msjg0tql1j99vp40dlhf7tv5ea